Nexgel, Inc.

Medical device company · Langhorne, Pennsylvania, United States · Nasdaq: NXGL

Nexgel, Inc. is a medical device company headquartered in Langhorne, Pennsylvania, United States. Its shares trade on Nasdaq under the ticker NXGL. The US FDA lists 1 medical device site registered to the company, with devices in general and plastic surgery. It has reported private securities offerings to the US SEC, most recently $1.6 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Nexgel at a glance

Typemedical device company
HeadquartersLanghorne, Pennsylvania, United States
Stock listingNasdaq: NXGL
SEC industrySurgical & Medical Instruments & Apparatus
FDA-registered sites1
SEC CIK1468929

What does Nexgel do?

Medical specialties of its FDA-listed devices

General and Plastic Surgery

Device types listed with the FDA

Dressing, wound and burn, hydrogel w/drug and/or biologicDressing, wound, drugDressing, wound, hydrogel without drug and/or biologic

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $1.6 million sold (2021).

Where is Nexgel located?

Headquarters: Langhorne, Pennsylvania, United States

  • Langhorne, PennsylvaniaNexgel, Inc. · FDA device site

Frequently asked questions about Nexgel

Where is Nexgel headquartered?

Nexgel, Inc. is headquartered in Langhorne, Pennsylvania, United States.

What does Nexgel do?

Nexgel, Inc. is a medical device company. Its FDA-listed medical devices fall under general and plastic surgery. Its SEC industry classification is Surgical & Medical Instruments & Apparatus.

Is Nexgel a public company?

Yes. Nexgel, Inc. trades on Nasdaq under the ticker NXGL.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences